CTLA4 and neoplasm: A subcutaneous xenograft nude mouse model was established to investigate the inhibitory effects of the combination regimen of CIK cells, chemotherapy, and cadonilimab (a PD-1/CTLA-4 bispecific antibody) on tumor growth and metastasis in vivo.